Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FLT3 Antikörper (Biotin)

Der Maus Monoklonal Anti-FLT3-Antikörper wurde für FACS validiert. Er ist geeignet, FLT3 in Proben von Human zu detektieren.
Produktnummer ABIN2660938

Kurzübersicht für FLT3 Antikörper (Biotin) (ABIN2660938)

Target

Alle FLT3 Antikörper anzeigen
FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))

Reaktivität

  • 147
  • 48
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 131
  • 29
  • 6
  • 2
  • 1
Maus

Klonalität

  • 131
  • 36
  • 1
Monoklonal

Konjugat

  • 78
  • 13
  • 9
  • 7
  • 7
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser FLT3 Antikörper ist konjugiert mit Biotin

Applikation

  • 116
  • 69
  • 42
  • 42
  • 39
  • 39
  • 19
  • 12
  • 12
  • 10
  • 9
  • 8
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Klon

BV10A4H2
  • Aufreinigung

    The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Do not freeze.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))

    Andere Bezeichnung

    CD135

    Hintergrund

    CD135 is a 130-160 kD type III tyrosine kinase receptor expressed on CD34+ hematopoietic stem cells, myelomonocytic progenitors, primitive B cell progenitors, and thymocytes. CD135 is also expressed on malignant hematopoietic cells including AML, ALL and CML-BC. CD135, also known as FMS-like tyrosine kinase-3, FLT3, STK-1, and Flk-2, is a growth factor receptor that binds the FLT3 ligand to promote the growth and differentiation of primitive hematopoietic cells. The intracytoplasmic domain of CD135 is modified by phosphorylation and has been shown to interact with Grb2, SOCS1, VAV1, and Shc.

    Pathways

    RTK Signalweg
Sie sind hier:
Chat with us!